Apoletto LTD Lyell Immunopharma, Inc. Transaction History
Apoletto LTD
- $260 Million
- Q3 2022
A detailed history of Apoletto LTD transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Apoletto LTD holds 15,093,969 shares of LYEL stock, worth $146 Million. This represents 42.56% of its overall portfolio holdings.
Number of Shares
15,093,969
Previous 15,093,969
-0.0%
Holding current value
$146 Million
Previous $98.4 Million
12.42%
% of portfolio
42.56%
Previous 27.22%
Shares
2 transactions
Others Institutions Holding LYEL
# of Institutions
114Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$195 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$155 Million9.84% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$146 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$130 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA11.9MShares$115 Million1.8% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $2.4B
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...